# Lipocine Inc.: Form 8-K, filed Oct 31, 2024

- Company: [Lipocine Inc.](/companies/lpcn.md) (CIK 1535955)
- Form: 8-K
- Filed: 2024-10-31
- Accepted by EDGAR: Oct 31, 2024, 13:35 ET
- Period: 2024-10-28
- Accession: 0001493152-24-043147
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1535955/000149315224043147/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1535955/000149315224043147/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1535955/000149315224043147/form8-k.htm

Filed Oct 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-043147. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.